Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2019 Filed Feb 14, 2019 21:17 UTC |
deSouza Francis ADirector · President and CEO
|
GrantCommon Stock | 1,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005995 · form4.xml · nonDerivative · entry 5 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,614 F4 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 121% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 5, 2016. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:17 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionCommon Stock | 8,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005995 · form4.xml · nonDerivative · entry 4 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 5, 2016. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:17 UTC |
deSouza Francis ADirector · President and CEO
|
Tax withholdingCommon Stock | 9,390 | $292.20 | $2,743,758.00 |
DisclosureSEC source: 0001127602-19-005995 · form4.xml · nonDerivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,797 Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:17 UTC |
deSouza Francis ADirector · President and CEO
|
GrantCommon Stock | 3,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005995 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,187 F2 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 121% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 8, 2015. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:17 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionCommon Stock | 16,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005995 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 8, 2015. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:15 UTC |
Dadswell CharlesSVP & General Counsel
|
Exercise / conversionPerformance Shares · Derivative | 4,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005994 · form4.xml · derivative · entry 4 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,127 shares Expires 2018-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 8, 2015. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 8, 2015. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 8, 2015. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:15 UTC |
Dadswell CharlesSVP & General Counsel
|
Tax withholdingCommon Stock | 1,974 | $292.20 | $576,802.80 |
DisclosureSEC source: 0001127602-19-005994 · form4.xml · nonDerivative · entry 3 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,957 F3 · balance_after: Balance includes 58 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:15 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantCommon Stock | 867 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005994 · form4.xml · nonDerivative · entry 2 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,931 F2 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 121% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 8, 2015. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:15 UTC |
Dadswell CharlesSVP & General Counsel
|
Exercise / conversionCommon Stock | 4,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005994 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 8, 2015. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 22:07 UTC |
SIEGEL SUSAN EDirector
|
GrantCommon Stock | 2,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004592 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,839 F1 · shares: Grant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:46 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 400 | $284.54 | $113,816.00 |
DisclosureSEC source: 0001127602-19-004109 · form4.xml · nonDerivative · entry 5 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,104 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 400 shares sold ranging from $284.31 to $284.82 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:46 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 1,000 | $283.73 | $283,730.00 |
DisclosureSEC source: 0001127602-19-004109 · form4.xml · nonDerivative · entry 4 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,504 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 1,000 shares sold ranging from $283.31 to $284.12 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:46 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 800 | $282.84 | $226,272.00 |
DisclosureSEC source: 0001127602-19-004109 · form4.xml · nonDerivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,504 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 800 shares sold ranging from $282.28 to $283.19 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:46 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 600 | $281.55 | $168,930.00 |
DisclosureSEC source: 0001127602-19-004109 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,304 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 600 shares sold ranging from $281.13 to $282.09 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:46 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 200 | $280.53 | $56,106.00 |
DisclosureSEC source: 0001127602-19-004109 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,904 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 200 shares sold ranging from $280.11 to $280.94 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:45 UTC |
EPSTEIN ROBERT SDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-19-004108 · form4.xml · derivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:45 UTC |
EPSTEIN ROBERT SDirector
|
SaleCommon Stock | 1,000 | $280.11 | $280,110.00 |
DisclosureSEC source: 0001127602-19-004108 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,256 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:45 UTC |
EPSTEIN ROBERT SDirector
|
Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-19-004108 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:44 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 124 | $280.11 | $34,733.64 |
DisclosureSEC source: 0001127602-19-004107 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,879 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 21:27 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 3,300 | $303.53 | $1,001,649.00 |
DisclosureSEC source: 0001127602-19-002736 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,979 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 21:38 UTC |
Hampton Malcolm GarretSVP Clinical Genomics Group
|
Tax withholdingCommon Stock | 327 | $305.24 | $99,813.48 |
DisclosureSEC source: 0001127602-19-001880 · form4.xml · nonDerivative · entry 1 Hampton Malcolm Garret · CIK 0001698265 · SVP Clinical Genomics Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,774 Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 21:35 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 3,300 | $296.20 | $977,460.00 |
DisclosureSEC source: 0001127602-19-001879 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,279 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:32 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Tax withholdingCommon Stock | 158 | $293.75 | $46,412.50 |
DisclosureSEC source: 0001127602-19-001779 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,595 Read SEC document |
| January 07, 2019 Filed Jan 8, 2019 22:17 UTC |
SAMAD SAMSVP and CFO
|
Tax withholdingCommon Stock | 213 | $307.89 | $65,580.57 |
DisclosureSEC source: 0001127602-19-001641 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,612 Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:05 UTC |
EPSTEIN ROBERT SDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $51.17 | $0.00 |
DisclosureSEC source: 0001127602-19-001365 · form4.xml · derivative · entry 4 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 1,000 shares Expires 2022-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:05 UTC |
EPSTEIN ROBERT SDirector
|
SaleCommon Stock | 1,000 | $294.71 | $294,710.00 |
DisclosureSEC source: 0001127602-19-001365 · form4.xml · nonDerivative · entry 3 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,256 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:05 UTC |
EPSTEIN ROBERT SDirector
|
Exercise / conversionCommon Stock | 1,000 | $51.17 | $51,170.00 |
DisclosureSEC source: 0001127602-19-001365 · form4.xml · nonDerivative · entry 2 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:01 UTC |
Dadswell CharlesSr VP & General Counsel
|
SaleCommon Stock | 124 | $294.71 | $36,544.04 |
DisclosureSEC source: 0001127602-19-001352 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · Sr VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,003 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $71.09 | $0.00 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · derivative · entry 18 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 4,000 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 100 | $296.78 | $29,677.56 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 17 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,838 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F13 · price: Weighted average sale price representing 100 shares sold ranging from $296.64 to $297.00 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 117 | $295.93 | $34,623.92 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 16 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F12 · price: Weighted average sale price representing 117 shares sold ranging from $295.56 to $296.18 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 232 | $294.73 | $68,377.94 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 15 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,055 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F11 · price: Weighted average sale price representing 232 shares sold ranging from $294.20 to $295.08 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 350 | $293.59 | $102,754.75 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 14 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,287 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F10 · price: Weighted average sale price representing 350 shares sold ranging from $293.02 to $294.01 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 134 | $292.27 | $39,163.55 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 13 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,637 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F9 · price: Weighted average sale price representing 134 shares sold ranging from $292.02 to $292.77 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 67 | $291.02 | $19,498.28 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 12 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,771 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F8 · price: Weighted average sale price representing 67 shares sold ranging from $290.63 to $291.42 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.\ Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 466 | $296.57 | $138,201.34 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 11 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,838 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F7 · price: Weighted average sale price representing 466 shares sold ranging from $296.18 to $297.00 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 365 | $295.72 | $107,937.98 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 10 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,304 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 365 shares sold ranging from $295.17 to $296.10 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 1,068 | $294.75 | $314,791.08 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 9 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,669 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 1,068 shares sold ranging from $294.17 to $295.08 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 1,202 | $293.63 | $352,940.74 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 8 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,737 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 1,202 shares sold ranging from $293.02 to $294.01 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 566 | $292.41 | $165,501.46 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 7 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,939 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 566 shares sold ranging from $292.02 to $293.00 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 333 | $291.03 | $96,912.72 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 6 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,505 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 333 shares sold ranging from $290.63 to $291.42 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:03 UTC |
EASTHAM KARINDirector
|
Exercise / conversionCommon Stock | 4,000 | $71.09 | $284,360.00 |
DisclosureSEC source: 0001127602-19-001359 · form4.xml · nonDerivative · entry 5 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:04 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 200 | $296.05 | $59,210.00 |
DisclosureSEC source: 0001127602-19-001361 · form4.xml · nonDerivative · entry 5 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,104 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 200 shares sold ranging from $295.81 to $296.28 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:04 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 600 | $294.93 | $176,958.00 |
DisclosureSEC source: 0001127602-19-001361 · form4.xml · nonDerivative · entry 4 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,304 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 600 shares sold ranging from $294.41 to $295.33 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:04 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 700 | $293.77 | $205,639.00 |
DisclosureSEC source: 0001127602-19-001361 · form4.xml · nonDerivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,904 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 700 shares sold ranging from $293.33 to $294.19 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:04 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 800 | $292.68 | $234,144.00 |
DisclosureSEC source: 0001127602-19-001361 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,604 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 800 shares sold ranging from $292.28 to $293.27 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:04 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 700 | $291.49 | $204,043.00 |
DisclosureSEC source: 0001127602-19-001361 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,404 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 700 shares sold ranging from $290.93 to $291.91 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| December 27, 2018 Filed Jan 4, 2019 22:05 UTC |
EPSTEIN ROBERT SDirector
|
GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-001365 · form4.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,256 Read SEC document |
| December 27, 2018 Filed Feb 12, 2019 22:33 UTC |
Stapley MarcEVP Strategy & Corp Developmt
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005451 · form5.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · EVP Strategy & Corp Developmt 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 15,238 Read SEC document |
| December 27, 2018 Filed Feb 12, 2019 22:33 UTC |
Stapley MarcEVP Strategy & Corp Developmt
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005451 · form5.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · EVP Strategy & Corp Developmt 10b5-1 filing: Not disclosed Ownership: Indirect · By Children Disclosed balance after: 300 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.